Related Experiment Video

Updated: Oct 23, 2026

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

Effects of metyrapone and dexamethasone on pro-gamma-MSH and ACTH levels in depressed patients

N Sonino1, G A Fava, M A Morphy

  • 1Institute of Semeiotica Medica, University of Padova, Italy.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|November 1, 1990
PubMed

Insights

Hypothalamic-pituitary-adrenal (HPA) axis hyperactivity in depression is complex. Pro-gamma-melanocyte-stimulating hormone (MSH) and ACTH levels suggest HPA axis dysregulation in depression involves more than just ACTH.

Area of Science:

  • Neuroendocrinology
  • Psychiatry
  • Molecular Biology

Background:

  • The hypothalamic-pituitary-adrenal (HPA) axis is implicated in depression.
  • The exact mechanisms of HPA axis hyperactivity in depression remain controversial.
  • Pro-gamma-melanocyte-stimulating hormone (MSH) may play a synergistic role with ACTH in corticosteroid secretion.

Purpose of the Study:

  • To investigate the roles of pro-gamma-MSH and ACTH in HPA axis regulation in major depressive disorder.
  • To compare plasma levels of pro-gamma-MSH and ACTH in patients with depression and healthy controls under basal and stimulated conditions.

Main Methods:

  • Plasma levels of pro-gamma-MSH and ACTH were measured in 30 drug-free male patients with major depressive disorder and 21 healthy controls.
  • Hormone levels were assessed under basal conditions.
  • Hormone responses to metyrapone stimulation and dexamethasone suppression tests were evaluated.

Main Results:

  • Baseline pro-gamma-MSH and ACTH levels were similar between depressed patients and controls.
  • Following metyrapone stimulation, pro-gamma-MSH levels were significantly higher in controls compared to depressed patients.
  • Dexamethasone suppression resulted in less ACTH suppression in depressed patients than in controls.

Conclusions:

  • HPA axis dysregulation in depression appears to be more complex than previously thought.
  • Peptides beyond ACTH, such as pro-gamma-MSH, may be involved in HPA axis abnormalities in depression.
  • These findings contribute to understanding the neuroendocrine basis of depression.

More Related Videos

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures03:07

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Published on: July 12, 2024

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...